Random mutagenesis and phage display technology as a tool for identifying ige epitopes of the birch pollen allergen Bet v 1
نویسندگان
چکیده
Background IgE-binding epitopes of the major birch pollen allergen Bet v 1 are dependent on the native structure of the allergen. To date, only a single IgE epitope has been identified. We aimed to identify additional epitopes by directed in vitro evolution of non-IgE-binding structural homologues to proteins carrying single IgE-binding patches. For that purpose, we chose cytokinin-specific binding protein (CSBP) from Vigna radiata (mung bean), a structural homologue of Bet v 1 with only 31% sequence identity, as a template subjected to a combination of random mutagenesis and phage display.
منابع مشابه
Monovalent fusion proteins of immunoglobulin E mimotopes are safe for therapy of type I allergy
By screening phage display random peptide libraries with purified immunoglobulin E (IgE) from birch pollen-allergic patients, we previously defined peptides mimicking natural IgE epitopes (mimotopes) of the major birch pollen allergen Bet v 1. The present study aimed to define a monovalent carrier for the IgE mimotopes to induce protective antibodies directed to the IgE epitopes, suitable for m...
متن کاملGeneration of a protein scaffold for the analysis of functional immunoglobulin epitopes of Bet v 1-like allergens
Background Millions of patients with allergy to tree pollen are sensitized to the major allergen of birch (Betula verrucosa) pollen, Bet v 1. Bet v 1-specific IgE cross-reacts with Bet v 1-homologous proteins from plant foods. Only little information on functional IgE epitopes of Bet v 1 and Bet v 1-like allergens in foods is available. We sought to generate a synthetic protein tool to identify...
متن کاملA nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Allergen-specific immunotherapy is the only allergen-specific and disease-modifying treatment for allergy. The construction and characterization of a vaccine for birch pollen allergy is reported. Two nonallergenic peptides, PA and PB, derived from the IgE-reactive areas of the major birch pollen allergen Bet v 1 were fused to the hepatitis B surface protein, PreS, in four recombinant fusion pro...
متن کاملImmunoglobulin E and G4 epitopes of the major allergen of birch pollen Bet v 1 share residues critical for antibody binding
Background Millions of patients with allergy to birch pollen develop clinically cross-reactive IgE against Bet v 1-like proteins in plant foods. Specific immunotherapy (SIT) with birch pollen extracts induces the biosynthesis of Bet v 1-specific immunoglobulin (Ig)G4. IgG4 is believed to act as a blocking antibody preventing IgE binding to Bet v 1, thus alleviating allergic symptoms. Only littl...
متن کاملAnalysis of potential immunoglobulin E epitopes of Gly m 4, a bet V 1-related allergen in soy beans
Binding and crosslinking of FcåRI-bound IgE to conformational epitopes on allergens causes hypersensitivity reactions in allergic patients. The knowledge and modulation of epitopes on the molecular level allows the design of both hypoallergenic recombinant variants of the allergen and specific antibodies for therapeutic and diagnostic purposes, respectively. We sought to identify and analyze th...
متن کامل